Inotersen sodium | Interleukin Related interleukin-related.com

Product Name :
Inotersen sodium

Search keywords :
Inotersen

drugId :
null

Target Vo:
Transthyretin

Target Vo Short Name :
TTR

Moa_Name:
RNA interference

First Approval Country :
EU

First Approval Date Filter:
2018

Origin Company_Name :
Ionis Pharmaceuticals Inc

Active Company_Name :
Akcea Therapeutics Inc

Active Indication_Name:
Transthyretin amyloidosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IKK alpha Antibody
MAPK14 Antibody
Thioredoxin Reductase 2 Antibody (YA661): Thioredoxin Reductase 2 Antibody (YA661) is a non-conjugated and Mouse origined monoclonal antibody about 57 kDa, targeting to Thioredoxin Reductase 2 (3F2). It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts